News & Updates
Filter by Specialty:
Electrofulguration effective against recurrent UTI in menopausal women
Treatment with electrofulguration for antibiotic-refractory recurrent urinary tract infections (UTI) demonstrates durable clinical cure and improvement over 5 years in menopausal women, reducing the need for long-term antibiotics, a study has shown.
Electrofulguration effective against recurrent UTI in menopausal women
25 Sep 2023Inadequate sleep tied to higher incidence of urgent urinary incontinence
Urgent urinary incontinence appears to occur more frequently among people with insufficient sleep than among those with moderate sleep duration, according to a study.
Inadequate sleep tied to higher incidence of urgent urinary incontinence
09 Sep 2023Novel systemic therapies improve survival in prostate cancer patients with visceral metastasis
Novel systemic treatments are similarly effective in reducing the risk of progression or death in patients with metastatic hormone-sensitive (mHSPC) and castration-resistant prostate cancer (mCRPC), irrespective of visceral metastasis status, reports a study.
Novel systemic therapies improve survival in prostate cancer patients with visceral metastasis
30 Aug 2023Working out heightens sexual function in men with prostate cancer
Prostate cancer treatment upends sexual function in men, but the good news is that supervised resistance and aerobic workout can counter these sexual side effects, according to a study presented at ASCO Breakthrough 2023.
Working out heightens sexual function in men with prostate cancer
29 Aug 2023Female stress urinary incontinence affects male partners’ sexual function
Stress urinary incontinence (SUI) in women appears to have a significant impact on their partners’ sexual function, suggests a study. Furthermore, female anti-incontinence surgery does not seem to improve the sexual function of their partners.
Female stress urinary incontinence affects male partners’ sexual function
29 Aug 2023Real-world data: High rates of complications and unplanned hospital admissions in mHSPC
Seventy percent of patients with metastatic hormone-sensitive prostate cancer (mHSPC) experience disease-related complications, while 59 percent require ≥1 unplanned hospital admission during the course of disease, a study by the Chinese University of Hong Kong (CUHK) has shown.